COPENHAGEN, Denmark--(BUSINESS WIRE)--Freya Biosciences, a trans-Atlantic biotech company specializing in women's health, announces positive topline results from its first Phase 1 clinical study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback